ERIN GOLDERMAN: Open Payments
NPI 1801577473 · DELMAR, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,137 in 60 payments from 16 companies in 2025. Trend: 2023 $551 · 2024 $2,741 · 2025 $1,137
Food & beverage: $1,137
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $329 |
| Lilly USA, LLC | 8 | $152 |
| Novo Nordisk Inc | 6 | $121 |
| GlaxoSmithKline, LLC. | 5 | $87 |
| Exact Sciences Corporation | 4 | $80 |
| PFIZER INC. | 4 | $72 |
| SANOFI-AVENTIS U.S. LLC | 2 | $52 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $50 |
| Lundbeck LLC | 2 | $47 |
Products named: QULIPTA, VRAYLAR, ELIQUIS, MOUNJARO, TZIELD, TRELEGY ELLIPTA, XIFAXAN, The Cologuard Plus Collection Kit.
Industry payments across NY — which companies pay providers there.
